Document Detail

Different In Vitro Systems Affect CYPIA1 Activity in Response to 2,3,7,8-Tetrachlorodibenzo-p-dioxin.
MedLine Citation:
PMID:  20654408     Owner:  NLM     Status:  In-Data-Review    
The induction of cytochrome P450IA1 (CYP1A1) activity in human hepatoma cell lines has been used as a model response for exposure to the environmental contaminant, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). CYP1A1 induction is mediated by the intracellular Ah receptor. We have designed a cell culture analogue system to evaluate the effect of low dose continuous exposures to TCDD such that the responses can be compared with traditional static in vitro exposures. The two-compartment model is designed to mimic aspects of time-dependent dose exposure in humans and consists of a 'liver' compartment with HepG2 cells and an 'other tissues' compartment. Exposure of microcarrier-attached HepG2 cells in spinner flask to a single dose of TCDD resulted in an EC(50) for ethoxyresorufin-o-deethylase (EROD) activity induction of 1.49nm. Using a one-compartment reactor with continuous TCDD dosing resulted in an EC(50) for EROD induction of 0.69nm TCDD. Finally, using a two-compartment reactor with continuous TCDD dosing resulted in an EC(50) for EROD induction of about 0.05nm. Parallel studies using (3)H-TCDD were performed to determine the amount of cell associated (3)H-TCDD and subsequently to estimate the amount of bound Ah receptor. CYPIA1 mediated EROD activities in both cell lines correlated with the estimated amount of bound Ah receptor. To illustrate how these systems might alter estimates of risk, the data were evaluated to estimate the TCDD level which would increase CYPIA1 mediated EROD activity to 0.01% of the maximal response. The two-compartment reactor data yielded an estimate of allowable TCDD exposure of 1x10(-5)nm for an acceptable 'risk' level of 0.01%. In contrast, values were estimated as 4x10(-4)nm from the one compartment reactor and 4x10(-3)nm from spinner flasks. This work demonstrates the importance of design of the in vitro system on risk assessment.
N A Mufti; M L Shuler
Related Documents :
20177898 - Erucylphospho-n,n,n-trimethylpropylammonium (erufosine) is a potential antimyeloma drug...
22886938 - Heterogeneity of intrinsically photosensitive retinal ganglion cells in the mouse revea...
20506578 - Synergistic effects of tea polyphenols and ascorbic acid on human lung adenocarcinoma s...
20650258 - Effects of fluoroquinolones and glucocorticoids on cultivated tendon cells in vitro.
9630218 - Sec6/8 complex is recruited to cell-cell contacts and specifies transport vesicle deliv...
18060348 - Transient expression of atnced3 and aao3 genes in guard cells causes stomatal closure i...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Toxicology in vitro : an international journal published in association with BIBRA     Volume:  12     ISSN:  0887-2333     ISO Abbreviation:  Toxicol In Vitro     Publication Date:  1998 Jun 
Date Detail:
Created Date:  2010-07-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8712158     Medline TA:  Toxicol In Vitro     Country:  England    
Other Details:
Languages:  eng     Pagination:  259-72     Citation Subset:  -    
School of Chemical Engineering, Cornell University, Ithaca, New York, 14853-5201, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Simultaneous evaluation of cell viability by neutral red, MTT and crystal violet staining assays of ...
Next Document:  Limitations of the mcf-7 cell proliferation assay for detecting xenobiotic oestrogens.